Objective
to compare 6 versus 12 months DAPT in patients treated with BP-DES
Study
multicentre, assessor-blind, non-inferiority RCT
Population
patients with stable CAD or ACS
Endpoints
TLR at 12 months
Conclusion
6-month dual antiplatelet therapy was non-inferior to 12 months in terms of TLF in patients treated with BP-DES
Han et al. Circ. Cardiovasc. Interv. 2018;9:e003145
